Overview Central & Peripheral Nervous System: Recent developments in serotonin reuptake inhibitors
- 1 April 1994
- journal article
- Published by Informa Healthcare in Expert Opinion on Therapeutic Patents
- Vol. 4 (4), 335-341
- https://doi.org/10.1517/13543776.4.4.335
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Absolute configuration of (+)‐cis‐2,3‐dihydro‐2‐[(methylamino)methyl]‐1‐ [4‐(trifluoromethyl)phenoxy]‐1H‐indene hydrochloride, a chiral serotonin uptake inhibitorChirality, 1993
- Iodinated tomoxetine derivatives as selective ligands for serotonin and norepinephrine uptake sitesJournal of Medicinal Chemistry, 1992
- SertralineDrugs, 1992
- Substituted N,N-Dimethyl-3-(phenylthio)- and -4-(phenylthio)benzylaminesCollection of Czechoslovak Chemical Communications, 1992
- A Review of Fluvoxamine and its Uses in DepressionInternational Clinical Psychopharmacology, 1991
- ParoxetineDrugs, 1991
- Potential antidepressants and selective inhibitors of 5-hydroxytryptamine re-uptake in the brain: Synthesis of several potential metabolites of moxifetin and of two A-ring fluorinated analoguesCollection of Czechoslovak Chemical Communications, 1991
- Potential antidepressants: 3-Aryl-3-(arylthio)propylamines as selective inhibitors of 5-hydroxytryptamine re-uptake in the brainCollection of Czechoslovak Chemical Communications, 1991
- AntidepressantsDrugs, 1989
- Potential antidepressants: 2-(Methoxy- and hydroxyphenylthio)benzylamines as selective inhibitors of 5-hydroxytryptamine re-uptake in the brainCollection of Czechoslovak Chemical Communications, 1989